Summer does not have to mean idle devices and postponed treatments. Cryomodulation™, patented precision cooling technology from Glacial® Skin, gives practices a clinically validated way to treat patients across every season, every skin type, and every point on the intensity spectrum, from standalone skin rejuvenation to post-laser recovery.
For providers already navigating the reality of seasonal slowdowns, the question is not whether seasonality costs revenue. It is what you can do about it right now.
When temperatures rise, and patients head outdoors, energy-based devices that require strict sun avoidance quietly fall off the schedule. From early May through the end of August, nearly half the calendar year, many of the highest-revenue modalities in a practice sit underutilized or entirely idle.
Dr. Chris Robb sees this firsthand:
"Asking patients to stay out of the sun from early May to the end of August is difficult. We end up having many modalities that sit a little bit more idle at certain times of the year."
--- Dr. Chris Robb
The financial math is blunt. A six-figure laser used ten times per week in January and three times per week in July is not experiencing seasonal variation; it is operating below half capacity for nearly half the year. Meanwhile, the overhead stays the same: staff, lease, utilities, maintenance. The revenue gap is real, and it repeats every single year.
But the patients have not disappeared. They are still booking, still spending, still looking for treatments they can do without rearranging their summer. The problem is not demand, it is that most practices do not have a device-based treatment they can confidently offer all summer long, across all skin types, without restriction.
This is where Glacial® Skin's Glacial® Glide and Glacial® Gloss treatments change the calculus for practices heading into summer.
Unlike heat- and light-based platforms, Cryomodulation™ works by delivering controlled cooling directly to the skin surface. It downregulates pro-inflammatory mediators, normalizes melanin transfer, and accelerates the exfoliation of damaged cells without creating thermal injury or photosensitivity.
That distinction matters for every month on the calendar, but it matters most in summer:
As standalone clinical treatment experiences, Glacial® Glide and Glacial® Gloss deliver visible results, calming redness, brightening skin tone, improving texture, and boosting hydration in a single session. These are not filler treatments to keep chairs occupied. They are clinically meaningful interventions that patients book, experience, and come back for.
Summer is not kind to skin. UV exposure, environmental heat, humidity, and outdoor activity create a persistent inflammatory burden that patients may not see on the surface, but that is actively affecting skin health underneath.
This is particularly relevant for patients with higher Fitzpatrick skin types. The inflammatory response triggered by UV exposure, heat, and even minor procedural intervention is a well-documented driver of post-inflammatory hyperpigmentation (PIH), the stubborn darkening and uneven pigmentation that can follow any event that provokes an inflammatory cascade in the skin5. For these patients, summer compounds the challenge: more UV exposure means more inflammatory triggers, and the consequences of that inflammation can persist long after the season ends.
Glacial Rx's patented precision cooling is FDA-cleared for the reduction of pain and inflammation. By delivering precision cooling that downregulates the inflammatory mediators at the source, the technology directly addresses the mechanism that underlies many of the skin concerns patients present with during summer months, from visible redness and edema to the deeper inflammatory processes that affect long-term skin quality and tone.
For providers, this creates a compelling clinical narrative: rather than waiting until fall to address the cumulative effects of summer on the skin, Cryomodulation offers a proactive intervention that works with patients' summer lifestyles rather than against them.
While standalone Cryomodulation treatments keep the schedule full during summer, the technology also elevates outcomes when paired with the procedures you are already performing.
This is where the clinical evidence is strongest. The Murray et al. study demonstrated that Cryomodulation after fractional resurfacing cuts pain by nearly 70% and meaningfully reduces edema and erythema. For patients undergoing aggressive treatments, such as ablative lasers, deep microneedling, and combination protocols, the traditional downtime equation has been: powerful results, but days (sometimes weeks) of visible recovery.
Cryomodulation compresses that recovery window. By addressing the inflammatory response immediately post-procedure, patients who would typically need to stay indoors for extended periods can resume their routines faster with less redness, less swelling, and greater comfort. In summer, that is the difference between a treatment patients will book and one they will postpone until October.
For patients with higher Fitzpatrick skin types considering laser procedures, the post-procedural inflammatory response carries additional clinical consideration. Addressing inflammation promptly and effectively is a fundamental component of optimizing outcomes across all skin types.
Even minimally invasive procedures like IPL can leave patients with temporary redness and swelling. A 10-minute Cryomodulation session immediately following treatment reduces visible inflammation and improves the post-procedure experience, turning what was previously "expect some redness for a few hours" into "you are ready to go."
Patients who have had too much sun present with UV-induced inflammation, erythema, edema, and thermal discomfort. Clinical guidelines for acute sunburn management consistently recommend cooling as a first-line intervention4. Cryomodulation delivers that cooling with medical-grade precision, calming the inflammatory cascade while promoting faster visible recovery.
For patients who spend summer outdoors, at the pool, on the golf course, at the beach, this becomes an immediate value proposition: come in, cool down, walk out looking and feeling better.
Reduced downtime and year-round availability are not just clinical advantages, they fundamentally change the patient relationship.
Consider the patient who typically books aggressive laser treatments in the fall and winter, then disappears from the schedule for five months. With standalone Cryomodulation treatments available through summer, that patient stays engaged maintaining skin quality, seeing results, and staying connected to your practice. When fall arrives, they are not a re-acquisition challenge. They are an active patient ready for their next intensive procedure.
Dr. Chris Robb noticed this behavioral shift quickly:
"This is a technology that I believe really adds new patients, but more importantly, it adds return patients." --- Dr. Chris Robb
That pattern of patients converting from seasonal visitors to year-round recurring appointments is where Cryomodulation's business impact compounds. A treatment that patients can repeat regularly, without sun restrictions, without downtime, across all skin types, creates the kind of continuous patient relationship that stabilizes revenue far more effectively than seasonal procedure surges.
Most practices have a structural gap in their offerings. On one end: aggressive device procedures with dramatic results, but significant downtime and seasonal limitations. On the other: lighter services with modest outcomes. Patients frequently find themselves caught between wanting real, visible results without the recovery commitment, especially in the summer.
Glacial® Glide and Glacial® Gloss treatments fill that gap while simultaneously enhancing outcomes across the spectrum:
The result is not replacing your existing treatments-it is making your entire treatment menu more usable, more often, for more patients.
A 2024 prospective, randomized, split-face study published in Lasers in Surgery and Medicine (Murray, Darji & Friedman) evaluated Cryomodulation immediately following nonablative fractional resurfacing with dual 1550 nm erbium and 1927 nm thulium fiber lasers. The findings were striking1:
Blinded physician reviewers correctly identified the Cryomodulation-treated side in 70% of photographs objective confirmation that the visible difference is real, not just patient perception.
Additional evidence supports cooling as a foundational intervention for skin health. A comprehensive review in the Journal of Clinical and Aesthetic Dermatology found that cooling protocols attenuate erythema intensity and accelerate resolution after laser resurfacing, while a 2022 literature review in Cosmetics (MDPI) confirmed that controlled cryotherapy improves skin hydration, reduces inflammatory markers, and supports tissue recovery across dermatologic applications2,3.
The most profitable device in your practice is not necessarily the one with the most impressive specifications. It is the one you can use every month of the year, on every patient who walks in, with results that bring them back.
Cryomodulation is backed by peer-reviewed clinical evidence, FDA clearance for the reduction of pain and inflammation, and patented precision cooling technology developed by founders from Massachusetts General Hospital, which delivers exactly that.
As summer arrives and your laser schedule starts to thin, the gap does not have to mean lost revenue, idle treatment rooms, and patients drifting to other providers. Standalone Cryomodulation treatments give your patients a reason to keep coming in, and give your practice a reason to keep growing.
The question is not whether you can afford to add Cryomodulation to your practice. It is whether you can afford another summer without it.
References